Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
2
×
boston blog main
boston top stories
gene therapy
2
×
life sciences
national blog main
national top stories
new york blog main
san diego blog main
2
×
san francisco blog main
adeno-associated virus
alexandria venture investments
altitude life science ventures
american society of gene and cell therapy
arch venture partners
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bluebird bio
boston
boxer capital
clinical trials
deals
dravet syndrome
duchenne muscular dystrophy
dyne therapeutics
ed kaye
encoded therapeutics
facioscapulohumeral muscular dystrophy
generation bio
hemophilia
illumina
illumina ventures
joshua brumm
kaleido biosciences
matrix capital management
menlo ventures
muscular dystrophy
myotonic dystrophy type 1
What
long
2
×
ago
biotechs
considering
crude
cutting
data
despite
diseases
drug
dyne
early
edge
effects
encoded
expected
experimental
eyes
gene
genetic
having
help
humans
illumina’s
ipo
ipos
lasting
limited
limits
medicine
medicines
muscle
nabs
progress
promising
push
rare
reach
remains
single
Language
unset
Current search:
biotech
×
long
×
" san diego blog main "
×
" gene therapy "
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
